FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method of endothelial dysfunction correction in patients with secondary lymphedema of lower extremities. Method comprises wearing compression jersey of compression class III and using endothelioprotector for 3 months, wherein the endothelioprotector used is a purified micronised flavonoid fraction, in terms of dry substance, 1000.00 mg, consisting of 900 mg of diosmine and 100 mg of flavonoids in terms of hesperidin orally once a day.
EFFECT: above described method provides correction of endothelial dysfunction in patients with secondary lymphedema of lower extremities.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING EFFICIENCY OF ENDOTHELIOTROPIC THERAPY AFTER RECONSTRUCTIVE OPERATIONS ON ARTERIES | 2015 |
|
RU2611386C2 |
| HERBAL MEDICINAL PRODUCT HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2014 |
|
RU2561064C1 |
| PHARMACEUTICAL COMPOSITION OF BIOFLAVONOIDS HESPERIDIN AND PINOSTROBIN POSSESSING ENDOTHELIUM PROTECTIVE, ANTICOAGULANT AND ACTOPROTECTIVE ACTION | 2014 |
|
RU2575790C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RESTENOSIS IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES AFTER ENDOVASCULAR INTERVENTIONS | 2022 |
|
RU2788896C1 |
| METHOD FOR PREDICTION OF COURSE OF OBLITERATING ARTERIOSCLEROSIS OF ARTERIES OF LOWER EXTREMITIES | 2019 |
|
RU2722159C1 |
| METHOD FOR EARLY DIAGNOSIS OF CHRONIC DISEASES OF THE PARANASAL SINUSES AND PALATINE TONSILS | 2021 |
|
RU2763821C1 |
| METHOD FOR DETERMINING LIKELIHOOD OF DEVELOPING COMPLICATED COURSE OF SECONDARY LYMPHEDEMA OF LOWER EXTREMITIES | 2022 |
|
RU2804222C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF CHEWABLE TABLET OF DIOSMIN OR FLAVONOID FRACTION | 2019 |
|
RU2811866C2 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH IRON-DEFICIENCY ANEMIA | 2009 |
|
RU2418589C2 |
| METHOD FOR DIAGNOSING ENDOTHELIAL DYSFUNCTION IN SMOKING PREGNANT WOMEN WITH ARTERIAL HYPERTENSION | 2021 |
|
RU2767927C1 |
